Literature DB >> 18366179

Binding of catechols to mononuclear titanium(IV) and to 1- and 5-nm TiO2 nanoparticles.

Carol Creutz1, Mei H Chou.   

Abstract

The binding of catechol derivatives (LH 2 = catechol, 4-methyl catechol, 4-t-butyl catechol, and dopamine) to 1- and 4.7-nm TiO2 nanoparticles in aqueous, pH 3.5 suspensions has been characterized by UV-vis spectroscopy. The binding constants derived from Benesi-Hildebrand plots are (2-4) x 10(3) M(-1) for the 1-nm nanoparticles and (0.4-1) x 10(4)M(-1) for the 4.7-nm particles. Ti(IV)L3 complexes were prepared from the same catechols. The L = methyl catechol, and dopamine complexes are reported for the first time. The TiL3 reduction potentials are not very sensitive to the nature of the catechol nor evidently are the binding constants to TiO2 nanoparticles. The intense (epsilon > or = 10(3) M(-1)cm(-1)), about 400-nm, ligand-to-metal charge-transfer (LMCT) absorptions of the nanoparticle complexes are compared with those of the TiL 3 complexes (epsilon approximately 10(4)M(-1) cm(-1)) which lie in the same spectral region. The nanoparticle colors are attributed (as are the colors of the Ti(IV)L3 complexes) to the tails of the about 400-nm LMCT bands.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18366179     DOI: 10.1021/ic701687k

Source DB:  PubMed          Journal:  Inorg Chem        ISSN: 0020-1669            Impact factor:   5.165


  8 in total

1.  LC-MS/MS determination of plasma catecholamines after selective extraction by borated zirconia.

Authors:  Juan Le; Ting Sun; Rui Peng; Teng-Fei Yuan; Yu-Qi Feng; Shao-Ting Wang; Yan Li
Journal:  Mikrochim Acta       Date:  2020-02-12       Impact factor: 5.833

2.  Characterization of noninnocent metal complexes using solid-state NMR spectroscopy: o-dioxolene vanadium complexes.

Authors:  Pabitra B Chatterjee; Olga Goncharov-Zapata; Laurence L Quinn; Guangjin Hou; Hiyam Hamaed; Robert W Schurko; Tatyana Polenova; Debbie C Crans
Journal:  Inorg Chem       Date:  2011-08-15       Impact factor: 5.165

3.  Epidermal growth factor receptor targeted nuclear delivery and high-resolution whole cell X-ray imaging of Fe3O4@TiO2 nanoparticles in cancer cells.

Authors:  Ye Yuan; Si Chen; Tatjana Paunesku; Sophie Charlotte Gleber; William C Liu; Caroline B Doty; Rachel Mak; Junjing Deng; Qiaoling Jin; Barry Lai; Keith Brister; Claus Flachenecker; Chris Jacobsen; Stefan Vogt; Gayle E Woloschak
Journal:  ACS Nano       Date:  2013-11-27       Impact factor: 15.881

4.  New antifouling platform characterized by single-molecule imaging.

Authors:  Ji Young Ryu; In Taek Song; K H Aaron Lau; Phillip B Messersmith; Tae-Young Yoon; Haeshin Lee
Journal:  ACS Appl Mater Interfaces       Date:  2014-02-17       Impact factor: 9.229

5.  Post-synthetic Ti exchanged UiO-66 metal-organic frameworks that deliver exceptional gas permeability in mixed matrix membranes.

Authors:  Stefan J D Smith; Bradley P Ladewig; Anita J Hill; Cher Hon Lau; Matthew R Hill
Journal:  Sci Rep       Date:  2015-01-16       Impact factor: 4.379

6.  Dye-sensitized electron transfer from TiO2 to oxidized triphenylamines that follows first-order kinetics.

Authors:  Brian N DiMarco; Ludovic Troian-Gautier; Renato N Sampaio; Gerald J Meyer
Journal:  Chem Sci       Date:  2017-11-17       Impact factor: 9.825

7.  Development of Fe3O4 core-TiO2 shell nanocomposites and nanoconjugates as a foundation for neuroblastoma radiosensitization.

Authors:  William Liu; Salida Mirzoeva; Ye Yuan; Junjing Deng; Si Chen; Barry Lai; Stefan Vogt; Karna Shah; Rahul Shroff; Reiner Bleher; Qiaoling Jin; Nghia Vo; Remon Bazak; Carissa Ritner; Stanley Gutionov; Sumita Raha; Julia Sedlmair; Carol Hirschmugl; Chris Jacobsen; Tatjana Paunesku; John Kalapurkal; Gayle E Woloschak
Journal:  Cancer Nanotechnol       Date:  2021-05-14

8.  Interfacial Charge Transfer Complexes in TiO2-Enediol Hybrids Synthesized by Sol-Gel.

Authors:  Claudio Imparato; Gerardino D'Errico; Wojciech Macyk; Marcin Kobielusz; Giuseppe Vitiello; Antonio Aronne
Journal:  Langmuir       Date:  2022-01-28       Impact factor: 3.882

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.